Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up (Q38021523)

27 August 2017

title

Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up (English)

1 reference

27 August 2017

1 reference

Maëlle de Ville de Goyet

series ordinal

1 reference

27 August 2017

Stéphane Moniotte

series ordinal

1 reference

27 August 2017

Bénédicte Brichard

series ordinal

1 reference

27 August 2017

publication date

25 June 2012

1 reference

Pediatric Hematology and Oncology

27 August 2017

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

395-414

1 reference

Outcomes for children and adolescents with cancer: challenges for the twenty-first century

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Chronic health conditions in adult survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Anthracycline associated cardiotoxicity in survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardiotoxicity of cancer chemotherapy: implications for children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Genetic variants contributing to daunorubicin-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Late effects among survivors of leukemia during childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

High-dose ifosfamide is associated with severe, reversible cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Long-term cardiac and pulmonary complications of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Radiation-associated cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Late effects of thoracic irradiation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Detection and monitoring of cardiotoxicity-what does modern cardiology offer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Comparison of physiological response to cardiopulmonary exercise testing among cancer survivors and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardiac changes associated with growth hormone therapy among children treated with anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Health status of the oldest adult survivors of cancer during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Late effects in long-term survivors after treatment for childhood acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Radiation-induced heart disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Long-term cardiac follow-up of children treated with anthracycline doses of 300â mg/m2or less for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2012.694092

10.3109/08880018.2012.694092

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference